Contraception is also known as birth control or fertility control, and it is a method or device used to prevent unwanted pregnancy. It has been used since ancient times, but effective and safe methods of birth control only became available in the 20th century. Planning, making available, and using birth control is called family planning. Some traditional or cultural barriers discourage the use of contraceptive methods because they consider it to be morally, religiously, or politically undesirable.

Global Contraceptive Devices Market Segments Size & Growth:

Global contraceptive devices market size is projected to reach approximately $18.8 billion by the end of 2024 with a CAGR of close to 7.72% from $11.77 billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include increased the incidence of the sexually transmitted diseases (STDs), increasing government initiatives and private firms to prevent unwanted abortions and pregnancies, high unmet contraceptive needs in developing economies, increasing population globally, effective contraception and fewer side effects of IUCDs, and conceivable non-contraception health benefits. However, stringent regulations and reimbursement policies, religious and cultural opposition towards contraceptive methods, the high cost of the treatment, constrained access in developing economies, and lack of awareness are thereby hindering the market growth. Various challenges of the contraceptive market include several concerns about side effects, and increasing elderly population pool and rise in infertility prevalence.

If a person is not using a contraceptive or incorrect use can result in an unintended pregnancy. The percentage of unintended pregnancies is higher among the teens younger than 18 years, followed by the age group of 20-24 years. In the United States, between 2009 and 2013, the proportion of pregnancies that were unintended increased slightly, from 49% to 51%, however, by 2014, the rate decreased to nearly 41%. Moreover, in 2014, contraceptives helped men to avoid about 2 million unintended pregnancies, which would likely have resulted in 900,000 unplanned births and nearly 700,000 abortions. However, from the past few years, the awareness on contraception has contributed to both fall in unwanted pregnancies and also growth in the usage of the contraceptives market.

Global Contraceptive Devices Market Segments Share:

Global contraceptive devices market is categorised into the type which comprises of condoms, diaphragms, cervical caps, sponges, vaginal rings, IUD, and implants. Among them, condoms segment is projected to hold the largest share in the market. Inexpensive, readily accessible, convenient, and no delay in fertility after their use are some of the benefits of using a condom. IUD segment is projected to witness the highest growth rate during the forecast period, and it is trustable, effective and is mainly used by women. By gender, the market is segmented into male and female. By end-users, the market is segmented into hospitals, homecare, gynaecology centres, clinics, ambulatory surgical centres (ASC), and others.

By Geography, North America is projected to hold the largest share in the market due to the rising incidence of unintended pregnancies, and increased use of contraceptive devices. However, Asia-Pacific is projected to be the fastest growing market due to growing awareness among people, increased incidence of unintended pregnancies & sexually transmitted diseases and several government initiatives. Favourable family planning policy along with other reimbursement policies such as the AIDS care policy will positively impact the growth of the market.

Global Contraceptive Devices Market Trends:

• The latest developments in contraceptive devices are the new long-acting reversible contraceptive (LARC) methods. They are progestogen-only implants, progestogen injections as well as intrauterine hormonal contraception (IUC) and copper intrauterine device (IUD) contraceptive methods.
• Teva Pharmaceuticals signed an agreement with CooperSurgical, where the company will acquire PARAGARD.

Global Contraceptive Devices Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The major market players, such as

• Bayer Healthcare Pharmaceuticals
• Merck & Co., Inc.
• Pfizer, Inc.
• Johnson & Johnson, Ltd
• Reckitt Benckiser Plc

Along with these companies, there were many other companies considered/cited in the report while analysing the global contraceptives device market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.